Skip to main content

Christopher Hoimes

Instructor in the Department of Medicine
Medicine, Medical Oncology
905 S LaSalle St, DUMC 103861 ; Rm 2010, Durham, NC 27710

Current Appointments & Affiliations


Instructor in the Department of Medicine · 2020 - Present Medicine, Medical Oncology, Medicine
Member of the Duke Cancer Institute · 2022 - Present Duke Cancer Institute, Institutes and Centers

In the News


Published May 17, 2024
Therapies Offer New Hope for Bladder Cancers

View All News

Recent Publications


Phase 1b/2 study of batiraxcept alone and in combination with cabozantinib with or without nivolumab for advanced clear cell renal cell carcinoma.

Journal Article Oncologist · June 4, 2025 BACKGROUND: Anexelokto (AXL) protein and its ligand, growth arrest specific-6 (GAS6), are important drivers of metastasis in patients with advanced clear cell renal cell carcinoma (ccRCC). Batiraxcept competitively binds GAS6 limiting interaction with AXL ... Full text Link to item Cite

Pembrolizumab plus enzalutamide for metastatic castration-resistant prostate cancer progressing on enzalutamide: cohorts 4 and 5 of the phase 2 KEYNOTE-199 study.

Journal Article Prostate Cancer Prostatic Dis · June 2025 BACKGROUND: KEYNOTE-199 (NCT02787005) is a multicohort phase 2 study evaluating pembrolizumab in patients with metastatic castration-resistant prostate cancer (mCRPC). Results from cohorts 4 (C4) and 5 (C5) are presented. METHODS: Eligible patients had not ... Full text Link to item Cite

Association of Tumor-informed Circulating Tumor DNA Detectability Before and After Radical Cystectomy with Disease-free Survival in Patients with Bladder Cancer.

Journal Article Eur Urol Oncol · April 2025 BACKGROUND AND OBJECTIVE: Despite curative-intent radical cystectomy (RC), patients with muscle-invasive bladder cancer (MIBC) are at high risk of recurrence. Biomarkers are urgently needed to refine prognostication and selection of appropriate perioperati ... Full text Link to item Cite
View All Publications

Education, Training & Certifications


New York Institute of Technology, College of Osteopathic Medicine · 2001 D.O.